Literature DB >> 29559137

Haemoparasitic agents associated with ovine babesiosis: A possible negative interaction between Babesia ovis and Theileria ovis.

Ferda Sevinc1, Mo Zhou2, Shinuo Cao2, Onur Ceylan3, Mehmet Fatih Aydin4, Mutlu Sevinc3, Xuenan Xuan2.   

Abstract

Babesiosis, theileriosis, and anaplasmosis are the most common tick-borne diseases in sheep. The majority of anaplasmosis and theileriosis are subclinical; however, babesiosis causes severe infections in small ruminants. Although there are many reports of co-infections with the agents of these diseases, their clinical severity compared with either of the infections alone is unknown. Within the host, interactions between co-infecting species may cause variations in clinical presentation and response to therapy. The aim of this study was to determine the tick-borne agents in sheep located at sites where fatal disease outbreaks caused by babesiosis have commonly been reported. Two hundred and nine sheep with clinical signs suggestive of ovine babesiosis were included in the study. The initial diagnosis of haemoparasites was based on clinical symptoms and microscopy and was confirmed using PCR assays. The blood samples were examined for the presence of Babesia ovis (B. ovis), Anaplasma ovis (A. ovis), A. phagocytophilum, and Theileria ovis (T. ovis). The results showed 86.12% of the animals were infected with one or more pathogens. B. ovis was the dominant pathogen. Overall, the infection rate of B. ovis, A. ovis, T. ovis, and A. phagocytophilum was 70.81%, 56.94%, 21.05%, and 2.39%, respectively. The infection rate of B. ovis alone (31.11%) was higher than A. ovis (9.44%) or T. ovis (1.67%) alone. Co-infections were found at a higher percentage (57.78%) than single infections (42.22%). A. ovis was detected in the blood of a high percentage (98.07%) of co-infected animals. Coexistence of B. ovis and A. ovis (34.45%) was more common than other combinations of species. There was a noticeably low level of co-occurrence between B. ovis and T. ovis (1.11%). During the study, 11 sick animals did not survive despite treatment. Seven were infected with B. ovis alone, three had a dual infection with B. ovis and A. ovis, and one had B. ovis, A. ovis, and T. ovis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anaplasma ovis; Babesia ovis; Sheep; Theileria ovis; cOexistence of tick-borne agents

Mesh:

Year:  2018        PMID: 29559137     DOI: 10.1016/j.vetpar.2018.02.013

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Epidemiology, risk factors, and co-infection of vector-borne pathogens in goats from Sistan and Baluchestan province, Iran.

Authors:  Hassan Hakimi; Ali Sarani; Mika Takeda; Osamu Kaneko; Masahito Asada
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

2.  Tick-Borne Hemoparasites of Sheep: A Molecular Research in Turkey.

Authors:  Onur Ceylan; Benedicto Byamukama; Ceylan Ceylan; Eloiza May Galon; Mingming Liu; Tatsunori Masatani; Xuenan Xuan; Ferda Sevinc
Journal:  Pathogens       Date:  2021-02-03

3.  The Scenario of Ticks and Tick-Borne Pathogens of Sheep on a Mediterranean Island.

Authors:  Anastasios Saratsis; Panagiota Ligda; Fredie Aal; Mandy Jelicic; Juliette Polgar; Myrthe de Vries; Ioannis Mastranestasis; Vincenzo Musella; Laura Rinaldi; Frans Jongejan; Smaragda Sotiraki
Journal:  Microorganisms       Date:  2022-07-31

4.  Epidemiological survey of Anaplasma marginale in cattle and buffalo in Sri Lanka.

Authors:  Atambekova Zhyldyz; Thillaiampalam Sivakumar; Ikuo Igarashi; Erandi Gunasekara; Hemal Kothalawala; Seekkuge Susil Priyantha Silva; Naoaki Yokoyama
Journal:  J Vet Med Sci       Date:  2019-09-20       Impact factor: 1.267

5.  Infection by haemopathogens and tick infestation of sheep during summer season in Constantine region, Northeast Algeria.

Authors:  Asma Amina Foughali; Mohamed Jedidi; Moktar Dhibi; Moez Mhadhbi; Limam Sassi; Ali Berber; Idir Bitam; Mohamed Gharbi
Journal:  Vet Med Sci       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.